#ProstateCancer cell metabolism dictates differentiation and therapy response. Andrew Goldstein joins Andrea Miyahira to discuss his group's findings published in Nature Cell Biology and how metabolic processes shape prostate cancer's response to treatment > bit.ly/49cwb6F

PARP inhibitor monotherapy for #ProstateCancer patients. Rashid K. Sayyid University of Toronto and Zach Klaassen Georgia Cancer Center provide an in-depth overview of the current evidence summarizing efficacy results from major trials and the adverse event profile of these agents > bit.ly/3TKfY3l

Sexual structure sparing for #ProstateCancer radiotherapy: a systematic review. #BeyondTheAbstract . Jennifer Le Guévelou CentreEugèneMarquis discusses work published in European Urology Oncology. #ReadNow > bit.ly/3UGphSR Paul Sargos Supiot Stéphane Ploussard Guillaume

Epidemiological trends and treatment innovations in advanced #ProstateCancer : An in-depth analysis of the Amer. Urol. Assn. amended 2023 guidelines. #JournalClub Rashid K. Sayyid University of Toronto & Zach Klaassen Georgia Cancer Center discuss on UroToday > bit.ly/3RW6X5b

A discussion between expert clinicians and patients on the #ProtecT trial, a #JournalClub for patients with #ProstateCancer . Matt Cooperberg UCSF Helen Diller Family Comprehensive Cancer Ctr leads a discussion with several experts on quality of life outcomes, the role of diet and exercise and more > bit.ly/42fnHJy

Care for adults with #SpinaBifida has a lot of room for improvement... thanks Ruchika Talwar for highlighting this important topic and eye-opening study!

Shout-out to superstar UCSF School of Medicine student Alejandro Lopez 💫 who propelled this across the finish line! (👀 uro res applicant!!)

Imaging response to PSMA radiopharmaceutical therapy. At the 2024 #PSMAConference Jeremie Calais highlights the advanced diagnostic capabilities of PSMA PET/SPECT in monitoring responses to PSMA-targeted radiopharmaceutical therapy > bit.ly/3uOg7cm PSMA conference - UCSF/UCLA/PCF/Urotoday

Highlighting #APCCC24 : An International Prostate Cancer Meeting! silke gillessen and aurelius omlin join Alicia Morgans, MD, MPH to discuss the upcoming meeting, April, 25-27 in #Lugano ! You don't want to miss this amazing event! bit.ly/42wB1cv Advanced Prostate Cancer Consensus Conference

The efficacy and resistance-breaking potential of EPI-7386 masofaniten in castration-resistant #ProstateCancer . Andy Laccetti MD, MS Memorial Sloan Kettering Cancer Center joins Zach Klaassen Georgia Cancer Center discussing the continuous effort to refine hormonal therapy in #PCa management > bit.ly/3OM2CAD

Explore expert consensus on key Advanced #ProstateCancer treatments.

Explore our collective views on next-gen imaging and its impact on treatment strategies.

Register now for #APCCC24 and be part of this crucial conversation 👉 apccc.org

#MedicalConsensus

#APCCC24 is just around the corner! ⏱️

Join us for Session 3 on Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), meticulously chaired by Sandy Srinivas Sandy Srinivas, Bertrand Tombal tombal , Mary-Ellen Taplin, and Karim Fizazi. This essential discussion will focus…

Just 10 days left until #APCCC24 !

Join us to shape the future of advanced #prostatecancer care with world-leading experts. Forge vital consensus on crucial strategies. Don't miss out!

👉 Register now: (link in bio ☝️)

#Oncology UroToday.com OncoAlert silke gillessen aurelius omlin

State of the art and future challenges of urethra-sparing stereotactic body radiotherapy for #ProstateCancer : a systematic review of the literature. #BeyondTheAbstract on UroToday > bit.ly/49NKz5V Jennifer Le Guévelou Thomas Zilli @WJUrol

Study reveals African ancestry gene variant is strongly linked to highly aggressive forms of #ProstateCancer . Mayuko Kanayama, MD, PhD The Johns Hopkins Brady Urological Institute joins Andrea Miyahira Prostate Cancer Foundation to discuss her team's research on a HOXB13 variant in this discussion > bit.ly/41SELF0

Optimizing #mHSPC care and collaboration for triplet therapy. Jason Hafron & Elisabeth Heath Karmanos Cancer Institute join Zach Klaassen Georgia Cancer Center to discuss the continuum of care in metastatic hormone-sensitive #ProstateCancer > bit.ly/3Vg3i5q MIU Men's Health Foundation

Novel antibody-drug conjugate combination yields high response in advanced #BladderCancer . Guru P. Sonpavde, MD and Bradley McGregor join Alicia Morgans, MD, MPH to discuss the #DAD trial, showing promise for adv urothelial carcinoma, ushering in new therapeutic possibilities > bit.ly/3NrbZ8e

Incorporating PSMA PET into radiotherapy planning: Impact on definitive therapy. Nicholas Nickols dives into the evolution of #ProstateCancer imaging. #WatchNow on UroToday > bit.ly/4bA0tSB PSMA conference - UCSF/UCLA/PCF/Urotoday UC San Francisco UCLA Prostate Cancer Foundation

Wolfgang Fendler sheds light on PSMA PET agents at the 2024 PSMA conference - UCSF/UCLA/PCF/Urotoday. Understanding ligand distribution and interpretation pitfalls is crucial, he advocates for inclusive trials to advance research and clinical use. #WatchNow > bit.ly/3SB3Aks Prostate Cancer Foundation

PSMA PET & the impact of the #PRIMARY trial. In this presentation, Louise Emmett St Vincent's Sydney explores enhancing #ProstateCancer diagnosis with PSMA PET imaging, revealing findings from the PRIMARY trial > bit.ly/3UFNWqQ PSMA conference - UCSF/UCLA/PCF/Urotoday

💫🌟🔍 National Comprehensive Cancer Network (NCCN) 2024 Prostate Cancer Guidelines Update 🚀🌟💫
Zach Klaassen Rashid K. Sayyid UroToday.com OncoAlert Advanced Prostate Cancer Consensus Conference urotoday.com/video-lectures…

🌟 New endorsement: ArteraAI Prostate Test for precision risk stratification
📈 Predicts biochemical recurrence, distant metastasis &…